Differential biological effects of aromatase inhibitors: Apoptosis, autophagy, senescence and modulation of the hormonal status in breast cancer cells
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 537, 111426
Abstract
No abstract availableKeywords
Funding Information
- Fundação para a Ciência e a Tecnologia
- Applied Molecular Biosciences Unit (UIDB/04378/2020)
This publication has 67 references indexed in Scilit:
- Apoptosis and Autophagy in Breast Cancer Cells following Exemestane TreatmentPLOS ONE, 2012
- Novel senescence associated gene, YPEL3, is repressed by estrogen in ER+ mammary tumor cells and required for tamoxifen‐induced cellular senescenceInternational Journal of Cancer, 2011
- An “Omics” Approach to Determine the Mechanisms of Acquired Aromatase Inhibitor ResistanceOMICS: A Journal of Integrative Biology, 2011
- Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health StudyLaboratory Investigation, 2011
- Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal WomenClinical Cancer Research, 2011
- The Ability to Generate Senescent Progeny as a Mechanism Underlying Breast Cancer Cell HeterogeneityPLOS ONE, 2010
- Senescence evasion by MCF-7 human breast tumor-initiating cellsBreast Cancer Research, 2010
- YPEL3, a p53-Regulated Gene that Induces Cellular SenescenceCancer Research, 2010
- Molecular characterization of aromatase inhibitor-resistant, tamoxifen-resistant and LTEDaro cell linesThe Journal of Steroid Biochemistry and Molecular Biology, 2010
- The Role of Amphiregulin in Exemestane-Resistant Breast Cancer Cells: Evidence of an Autocrine LoopCancer Research, 2008